000 01284 a2200397 4500
005 20250511215916.0
264 0 _c19910522
008 199105s 0 0 eng d
022 _a0009-9236
024 7 _a10.1038/clpt.1991.52
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSandouk, P
245 0 0 _aMorphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cApr 1991
300 _a442-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aInjections, Intraventricular
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMorphine
_xblood
650 0 4 _aNeoplasms
_xcomplications
650 0 4 _aPain Measurement
650 0 4 _aPain, Intractable
_xdrug therapy
650 0 4 _aRadioimmunoassay
700 1 _aSerrie, A
700 1 _aUrtizberea, M
700 1 _aDebray, M
700 1 _aGot, P
700 1 _aScherrmann, J M
773 0 _tClinical pharmacology and therapeutics
_gvol. 49
_gno. 4
_gp. 442-8
856 4 0 _uhttps://doi.org/10.1038/clpt.1991.52
_zAvailable from publisher's website
999 _c2021913
_d2021913